UCSF

Tagged: pharmacogenetics

Rada Savic, PhD

Professor

I investigate the causes of variations in clinical outcomes, using computational methods. My goal is to determine the optimal dosage, timing, and duration of therapeutic regimens. Ultimately, I want to develop precise, personalized treatments.

Deanna Kroetz, PhD

Professor

My research seeks to understand the contribution of genetic variation to drug toxicity, to identify genetic biomarkers that can be used to guide effective use of drugs in the treatment of cancer and HIV, and to use genetics to unravel the molecular basis of drug-induced toxicity.

Kathy Giacomini, PhD

CERSI Co-Director & Professor

My research focuses on membrane transporters, which are of great importance to drug disposition and response. I am particularly interested in genetic variants in membrane transporters that are determinants of drug response and in harnessing transporters to enhance drug targeting. 

Drug safety is the aim of UCSF-Optivia research partnership

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescri

Giacomini to receive Therapeutic Frontiers Lecture Award

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at

Giacomini to lead $15.1 million in research funding to improve the use of drugs in individuals

Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how ge

Pharmacogenomics research spans school agenda

Pharmacogenomics research at the UCSF School of Pharmacy extends from a better understanding of information derived from the Human Genome Project to research on specific genetic differences in humans and how they might affect an individual's response to a medication.

Kroetz elected fellow of American Association of Pharmaceutical Scientists

Deanna Kroetz, PhD, UCSF School of Pharmacy faculty member, has been elected as a fellow of the American Association of Pharmaceutical Scientists (AAPS).

Pages